Boston biotechnology startup that uses plastic chips to simulate human organs to test medicines outside of the body said Tuesday that two more pharmaceutical giants and a major California teaching hospital plan to use its technology to develop drugs.

Emulate, which makes so-called organ-on-a-chip systems to test whether drugs are safe and effective, announced partnerships with Japan-based Takeda Pharmaceutical (TKPYY), Swiss-based Roche (RHHBY), and Cedars-Sinai Medical Center, of Los Angeles.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.